ACTINIUM PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $6.8M | $80.4M | $77.8M |
| FY2022 | $47.7M | $114.2M | $108.9M |
| FY2023 | $45.1M | $81.4M | $76.7M |
| FY2024 | $44.1M | $76.9M | $72.9M |
| FY2025 | $43.9M | $51.8M | $48.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $6.8M | $80.4M | $77.8M |
| FY2022 | $47.7M | $114.2M | $108.9M |
| FY2023 | $45.1M | $81.4M | $76.7M |
| FY2024 | $44.1M | $76.9M | $72.9M |
| FY2025 | $43.9M | $51.8M | $48.0M |